Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

409 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bidirectional epithelial-mesenchymal crosstalk provides self-sustaining profibrotic signals in pulmonary fibrosis.
Yao L, Zhou Y, Li J, Wickens L, Conforti F, Rattu A, Ibrahim FM, Alzetani A, Marshall BG, Fletcher SV, Hancock D, Wallis T, Downward J, Ewing RM, Richeldi L, Skipp P, Davies DE, Jones MG, Wang Y. Yao L, et al. Among authors: richeldi l. J Biol Chem. 2021 Sep;297(3):101096. doi: 10.1016/j.jbc.2021.101096. Epub 2021 Aug 18. J Biol Chem. 2021. PMID: 34418430 Free PMC article.
Recent Advances and Future Needs in Interstitial Lung Diseases.
Jones MG, Richeldi L. Jones MG, et al. Among authors: richeldi l. Semin Respir Crit Care Med. 2016 Jun;37(3):477-84. doi: 10.1055/s-0036-1580688. Epub 2016 May 27. Semin Respir Crit Care Med. 2016. PMID: 27231869 Review.
Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosis.
Jones MG, Fabre A, Schneider P, Cinetto F, Sgalla G, Mavrogordato M, Jogai S, Alzetani A, Marshall BG, O'Reilly KM, Warner JA, Lackie PM, Davies DE, Hansell DM, Nicholson AG, Sinclair I, Brown KK, Richeldi L. Jones MG, et al. Among authors: richeldi l. JCI Insight. 2016 Apr 21;1(5):e86375. doi: 10.1172/jci.insight.86375. JCI Insight. 2016. PMID: 27275013 Free PMC article.
The safety of new drug treatments for idiopathic pulmonary fibrosis.
Fletcher S, Jones MG, Spinks K, Sgalla G, Marshall BG, Limbrey R, Richeldi L. Fletcher S, et al. Among authors: richeldi l. Expert Opin Drug Saf. 2016 Nov;15(11):1483-1489. doi: 10.1080/14740338.2016.1218470. Epub 2016 Aug 17. Expert Opin Drug Saf. 2016. PMID: 27532218 Review.
Idiopathic pulmonary fibrosis.
Richeldi L, Collard HR, Jones MG. Richeldi L, et al. Lancet. 2017 May 13;389(10082):1941-1952. doi: 10.1016/S0140-6736(17)30866-8. Epub 2017 Mar 30. Lancet. 2017. PMID: 28365056 Review.
The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis.
Conforti F, Davies ER, Calderwood CJ, Thatcher TH, Jones MG, Smart DE, Mahajan S, Alzetani A, Havelock T, Maher TM, Molyneaux PL, Thorley AJ, Tetley TD, Warner JA, Packham G, Ganesan A, Skipp PJ, Marshall BJ, Richeldi L, Sime PJ, O'Reilly KMA, Davies DE. Conforti F, et al. Among authors: richeldi l. Oncotarget. 2017 Jul 25;8(30):48737-48754. doi: 10.18632/oncotarget.17114. Oncotarget. 2017. PMID: 28467787 Free PMC article.
409 results